Mitsuhiro Takenoyama

A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors

Toshihiko Doi, Kei Muro, Hiroshi Ishii et al. · Clinical Cancer Research · 2019 · 152 citations

Medicine, Oncology, Pharmacology +17

Acquired resistance to gefitinib: The contribution of mechanisms other than the T790M, MET, and HGF status

Takamitsu Onitsuka, Hidetaka Uramoto, Naohiro Nose et al. · Lung Cancer · 2009 · 151 citations

Medicine, Pharmacology, Pharmacotherapy +10

Prognostic Impact of Micrometastatic Tumor Cells in the Lymph Nodes and Bone Marrow of Patients With Completely Resected Stage I Non–Small-Cell Lung Cancer

Toshihiro Osaki, Tsunehiro Oyama, Chundong Gu et al. · Journal of Clinical Oncology · 2002 · 137 citations

Medicine, Oncology, Pathology +13

A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)

Takekazu Iwata, Ichiro Yoshino, Shigetoshi Yoshida et al. · Respiratory Research · 2016 · 126 citations · Full text

Medicine, Perioperative Medicine, Surgery +14

Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer

Kentaro Tanaka, Kumiko Isse, Tomomichi Fujihira et al. · Lung Cancer · 2017 · 120 citations

Medicine, Molecular Biology, Oncology +12